Evaluation of retinal thickness and of pseudophakic cystoid macular edema incidence in patients with primary open-angle glaucoma treated with prostaglandin analogues

Abstract

Background. Cataract is often associated with primary glaucoma. Prostaglandin analogues use is considered to be a risk factor for pseudophakic cystoid macular edema.

Purpose. To evaluate the effect of prostaglandin analogues and non-steroidal anti-inflammatory drops on the central retinal thickness and the incidence of pseudophakic cystoid macular edema after phacoemulsification with intraocular lens implantation in patients with primary open-angle glaucoma.

Materials and methods. 91 patients were enrolled in the study. 22 patients (22 eyes) were included in the first main group and 22 patients (22 eyes) were included in the second main groups. All patients in main groups had glaucoma and used prostaglandin analogues. 47 patients (57 eyes) without glaucoma were included in the control group. All patients were treated with topical antibiotics and steroids after phacoemulsification. Patients in the main second and in the control groups also received non-steroidal anti-inflammatory drops. The retinal thickness was measured by optical coherence tomography 2 weeks, 2 months and 6 months after the operation.

Results. After the operation, the foveal thickness in patients of the first and the second groups was increased, but it had returned to the preoperative level after 6 months in the first group and after 2 months in the second group. The retinal thickness in the fovea in the control group decreased after the surgery and it has been increasing gradually but did not achieve the preoperative value.

Conclusion. Prostaglandin analogues use after phacoemulsification with intraocular lens implantation does not affect the incidence of pseudophakic cystoid macular edema. Prescribing non-steroidal anti-inflammatory drops after the surgery helps to achieve faster normalization of the central retinal thickness.

Keywords

retinal thickness / fovea / phacoemulsification / primary open-angle glaucoma / prostaglandin analogues / pseudophakic cystoids macular edema / non-steroidal anti-inflammatory drops / optical coherence tomography

References

[1] Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica. 2010;224 Suppl 1:8–15. DOI: 10.1159/000315155

[2] Scholl S., Kirchhof J., Augustin A.J. Pathophysiology of macular edema // Ophthalmologica. 2010. Vol. 224, Suppl 1. P. 8–15. DOI: 10.1159/000315155

[3] Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36(5):599–619. DOI: 10.1016/0002-9394(53)90302-x

[4] Irvine S.R. A newly defined vitreous syndrome following cataract surgery // Am J Ophthalmol. 1953. Vol. 36, No. 5. P. 599–619. DOI: 10.1016/0002-9394(53)90302-x

[5] Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966;76(5):646–661. DOI: 10.1001/archopht.1966.03850010648005

[6] Gass J.D., Norton E.W. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966. Vol. 76, No. 5. P. 646–661. DOI: 10.1001/archopht.1966.03850010648005

[7] Gass JD, Norton EW. Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc. 1966;64:232–249.

[8] Gass J.D., Norton E.W. Fluorescein studies of patients with macular edema and papilledema following cataract extraction // Trans Am Ophthalmol Soc. 1966. Vol. 64. P. 232–249.

[9] Han JV, Patel DV, Squirrell D, McGhee CN. Cystoid macular oedema following cataract surgery: A review. Clin Exp Ophthalmol. 2019;47(3):346–356. DOI: 10.1111/ceo.1351

[10] Han J.V., Patel D.V., Squirrell D., McGhee C.N. Cystoid macular oedema following cataract surgery: A review // Clin Exp Ophthalmol. 2019. Vol. 47, No. 3. P. 346–356. DOI: 10.1111/ceo.13513

[11] Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634.

[12] Flach A.J. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery // Trans Am Ophthalmol Soc. 1998. Vol. 96. P. 557–634.

[13] Ioshin IE. Postoperative, or pseudophakic, macular edema. Russian Ophthalmological Journal. 2020;13(4):64–69. (In Russ.) DOI: 10.21516/2072-0076-2020-13-4-64-69

[14] Иошин И.Э. Послеоперационный или артифакичный (псевдофакичный) макулярный отёк // Российский офтальмологический журнал. 2020. Т. 13. № 4. С. 64–69. DOI: 10.21516/2072-0076-2020-13-4-64-69 Hwang H.S., Ahn Y.J., Lee H.J., et al. Comparison of macular thickness and inflammatory cytokine levels after microincision versus small incision coaxial cataract surgery // Acta Ophthalmol. 2016. Vol. 94, No. 3. P. e189–194. DOI: 10.1111/aos.12716

[15] Hwang HS, Ahn YJ, Lee HJ, et al. Comparison of macular thickness and inflammatory cytokine levels after microincision versus small incision coaxial cataract surgery. Acta Ophthalmol. 2016;94(3): e189–194. DOI: 10.1111/aos.12716

[16] Gulkilik G., Kocabora S., Taskapili M., Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity // Can J Ophthalmol. 2006. Vol. 41, No. 6. P. 699–703. DOI: 10.3129/i06-062

[17] Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol. 2006;41(6):699–703. DOI: 10.3129/i06-062

[18] Yonekawa Y., Kim I.K. Pseudophakic cystoid macular edema // Curr Opin Ophthalmol. 2012. Vol. 23, No. 1. P. 26–32. DOI: 10.1097/ICU.0b013e32834cd5f8

[19] Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23(1):26–32. DOI: 10.1097/ICU.0b013e32834cd5f8

[20] Lobo C. Pseudophakic cystoid macular edema // Ophthalmologica. 2012. Vol. 227, No. 2. P. 61–67. DOI: 10.1159/000331277

[21] Lobo C. Pseudophakic cystoid macular edema. Ophthalmologica. 2012;227(2):61–67. DOI: 10.1159/000331277

[22] Кокорев В.Л. Анализ факторов риска развития макулярного отёка после факоэмульсификации катаракты // Офтальмология. 2019. Т. 16. № 2. С. 185–191. DOI: 10.18008/1816-5095-2019-2-185-191

[23] Kokorev VL. The Analysis of Risk Factors of Development of Macular Edema after Phacoemulsification. Ophthalmology in Russia. 2019;16(2):185–191. (In Russ.) DOI: 10.18008/1816-5095-2019-2-185-191

[24] Еричев В.П., Козлова И.В., Косова Д.В., и др. Динамика морфометрических параметров макулярной зоны у пациентов с глаукомой после факоэмульсификации // Вестник офтальмологии. 2019. Т. 135. № 5–2. С. 129–134. DOI: 10.17116/oftalma2019135052129

[25] Erichev VP, Kozlova IV, Kosova DV, et al. Dynamics of changes in morphometric parameters of the macular zone in glaucoma patients after phacoemulsification. The Russian Annals of Ophthalmology. 2019;135(5–2):129–134. (In Russ.) DOI: 10.17116/oftalma2019135052129

[26] Gharbiya M., Cruciani F., Cuozzo G., et al. Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification // Eye (Lond). 2013. Vol. 27, No. 5. P. 605–611. DOI: 10.1038/eye.2013.28

[27] Gharbiya M, Cruciani F, Cuozzo G, et al. Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification. Eye (Lond). 2013;27(5):605–611. DOI:10.1038/eye.2013.28

[28] Iliff W.J. Aphakic cystoid macular edema and the operating microscope: is there a connection? // Trans Am Ophthalmol Soc. 1985. Vol. 83. P. 476–500.

[29] Iliff WJ. Aphakic cystoid macular edema and the operating microscope: is there a connection? Trans Am Ophthalmol Soc. 1985;83:476–500.

[30] 16. Астахов С.Ю., Гобеджишвили М.В. Послеоперационный макулярный отёк, синдром Ирвина Гасса // Клиническая офтальмология. 2010. Т. 11. № 1. С. 5–8.

[31] Astakhov SYu, Gobedzhishvili MV. Postoperative macular edema, syndrome Irvine Gass. Clinical Ophthalmology. 2010;11(1):5–8. (In Russ.)

[32] Kessel L., Tendal B., Jørgensen K.J., et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review // Ophthalmology. 2014. Vol. 121, No. 10. P. 1915–1924. DOI: 10.1016/j.ophtha.2014.04.035

[33] Kessel L, Tendal B, Jørgensen KJ, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915–1924. DOI: 10.1016/j.ophtha.2014.04.035

[34] Астахов С.Ю., Астахов Ю.С., Гобеджишвили М.В. Влияние лечения аналогами простагландинов на толщину сетчатки после факоэмульсификации с имплантацией интраокулярной линзы у больных первичной открытоугольной глаукомой // Офтальмологические ведомости. 2014. Т. 7. № 3. C. 73–76. DOI: 10.17816/OV2014373-76

[35] Astakhov SY, Astakhov YS, Gobedzhishvili MV. The influence of prostaglandin analogs on the retinal thickness after phacoemulsification with intraocular lens implantation in primary open-angle glaucoma patients. Ophthalmology Journal. 2014;7(3):73–76. (In Russ.) DOI: 10.17816/OV2014373-76

[36] Miyake K., Ibaraki N. Prostaglandins and cystoid macular edema // Surv Ophthalmol. 2002. Vol. 47, Suppl 1. P. S203–S218. DOI: 10.1016/s0039-6257(02)00294-1

[37] Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47 Suppl 1: S203–S218. DOI: 10.1016/s0039-6257(02)00294-1

[38] Warwar R.E., Bullock J.D., Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients // Ophthalmology. 1998. Vol. 105, No. 2. P. 263–268. DOI: 10.1016/s0161-6420(98)92977-3

[39] Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology. 1998;105(2):263–268. DOI: 10.1016/s0161-6420(98)92977-3

[40] Lima M.C., Paranhos A. Jr., Salim S., et al. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost // J Glaucoma. 2000. Vol. 9, No. 4. P. 317–321. DOI: 10.1097/00061198-200008000-00006

[41] Lima MC, Paranhos A Jr, Salim S, et al. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J Glaucoma. 2000;9(4):317–321. DOI: 10.1097/00061198-200008000-00006

[42] Camras C.B., Alm A., Watson P., Stjernschantz J. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups // Ophthalmology. 1996. Vol. 103, No. 11. P. 1916–1924. DOI: 10.1016/s0161-6420(96)30407-7

[43] Camras CB, Alm A, Watson P, Stjernschantz J. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology. 1996;103(11):1916–1924. DOI: 10.1016/s0161-6420(96)30407-7

[44] Yousufzai S.Y., Ye Z., Abdel-Latif A.A. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species // Exp Eye Res. 1996. Vol. 63, No. 3. P. 305–310. DOI: 10.1006/exer.1996.0119

[45] Yousufzai SY, Ye Z, Abdel-Latif AA. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res. 1996;63(3):305–310. DOI: 10.1006/exer.1996.0119

[46] Джавадова Г.Ч., Иошин И.Э., Мусаев П.И., Гулиева С.Т. Роль аналогов простагландинов в развитии макулярного отёка при периоперационном применении у больных катарактой, сочетанной с первичной открытоугольной глаукомой // Вестник Витебского государственного медицинского университета. 2019. Т. 18. № 6. С. 8–15. DOI: 10.22263/2312-4156.2019.6.8

[47] Javadova GCh, Ioshin IE, Musayev PI, Guliyeva ST. The role of prostaglandin analogs in the development of macular edema on their perioperative application in patients suff ering from cataract with concurrent primary open-angle glaucoma. Vestnik of Vitebsk State Medical University. 2019. Vol. 18, No. 6. P. 8–15. (In Russ.) DOI: 10.22263/2312-4156.2019.6.8

[48] Miyake K., Ota I., Maekubo K., et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias // Arch Ophthalmol. 1999. Vol. 117, No. 1. P. 34–40. DOI: 10.1001/archopht.117.1.34

[49] Miyake K, Ota I, Maekubo K, et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117(1):34–40. DOI:10.1001/archopht.117.1.34

[50] Arcieri E.S., Santana A., Rocha F.N., et al. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial // Arch Ophthalmol. 2005. Vol. 123, No. 2. P. 186–192. DOI: 10.1001/archopht.123.2.186

[51] Arcieri ES, Santana A, Rocha FN, et al. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial. Arch Ophthalmol. 2005;123(2):186–192. DOI: 10.1001/archopht.123.2.186

[52] Yüksel N., Doğu B., Karabaş V.L., Cağlar Y. Foveal thickness after phacoemulsification in patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, or primary open-angle glaucoma // J Cataract Refract Surg. 2008. Vol. 34, No. 11. P. 1953–1957. DOI: 10.1016/j.jcrs.2008.07.016

[53] Yüksel N, Doğu B, Karabaş VL, Cağlar Y. Foveal thickness after phacoemulsification in patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, or primary open-angle glaucoma. J Cataract Refract Surg. 2008;34(11):1953–1957. DOI: 10.1016/j.jcrs.2008.07.016

[54] Puliafito C.A., Hee M.R., Lin C.P., et al. Imaging of macular diseases with optical coherence tomography // Ophthalmology. 1995. Vol. 102, No. 2. P. 217–229. DOI: 10.1016/s0161-6420(95)31032-9

[55] Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102(2):217–229. DOI: 10.1016/s0161-6420(95)31032-9

[56] Jaffe G.J., Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma // Am J Ophthalmol. 2004. Vol. 137. No. 1. P. 156–169. DOI: 10.1016/s0002-9394(03)00792-x

[57] Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004;137(1):156–169. DOI: 10.1016/s0002-9394(03)00792-x

[58] Chu C.J., Johnston R.L., Buscombe C., et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes // Ophthalmology. 2016. Vol. 123, No. 2. P. 316–323. DOI: 10.1016/j.ophtha.2015.10.001

[59] Chu CJ, Johnston RL, Buscombe C, et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology. 2016;123(2):316–323. DOI: 10.1016/j.ophtha.2015.10.001

[60] Алексеев И.Б. Самойленко А.И., Адлейба О.А., и др. Влияние аналогов простагландинов на результаты факоэмульсификации катаракты у больных первичной открытоугольной глаукомой // Российский офтальмологический журнал. 2012. Т. 5. № 2. С. 4–7.

[61] Alekseev IB, Samoylenko AI, Adleyba OA, et el. The impact of prostaglandin analogs on the results of cataract phacoemulsification in patients with primary open-angle glaucoma. Russian Ophthalmological Journal. 2012;5(2):4–7. (In Russ.)

[62] von Jagow B., Ohrloff C., Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography // Graefes Arch Clin Exp Ophthalmol. 2007. Vol. 245, No. 12. P. 1765–1771. DOI: 10.1007/s00417-007-0605-6

[63] von Jagow B, Ohrloff C, Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2007;245(12):1765–1771. DOI: 10.1007/s00417-007-0605-6

[64] Perente I., Utine C.A., Ozturker C., et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography // Curr Eye Res. 2007. Vol. 32, No. 3. P. 241–247. DOI: 10.1080/02713680601160610

[65] Perente I, Utine CA, Ozturker C, et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007;32(3):241–247. DOI: 10.1080/02713680601160610

[66] Ching H.Y., Wong A.C., Wong C.C., et al. Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomography // Eye (Lond). 2006. Vol. 20, No. 3. P. 297–303. DOI: 10.1038/sj.eye.6701864

[67] Ching HY, Wong AC, Wong CC, et al. Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomography. Eye (Lond). 2006;20(3):297–303. DOI: 10.1038/sj.eye.6701864

[68] Kurt A., Kılıç R. The Effects of Uncomplicated Cataract Surgery on Retinal Layer Thickness // Journal of Ophthalmology. 2018. Vol. 2018. P. 1–6. DOI: 10.1155/2018/7218639

[69] Kurt A, Kılıç R. The Effects of Uncomplicated Cataract Surgery on Retinal Layer Thickness. Journal of Ophthalmology.2018;2018:1–6. DOI: 10.1155/2018/7218639

[70] Cagini C., Fiore T., Iaccheri B., et al. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery // Curr Eye Res. 2009. Vol. 34, No. 12. P. 1036–1041. DOI: 10.3109/02713680903288937

[71] Cagini C, Fiore T, Iaccheri B, et al. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Curr Eye Res. 2009;34(12):1036–1041. DOI: 10.3109/02713680903288937

[72] Falcão M.S., Gonçalves N.M., Freitas-Costa P., et al. Choroidal and macular thickness changes induced by cataract surgery // Clin Ophthalmol. 2014. Vol. 8. P. 55–60. DOI: 10.2147/OPTH.S53989

[73] Falcão MS, Gonçalves NM, Freitas-Costa P, et al. Choroidal and macular thickness changes induced by cataract surgery. Clin Ophthalmol. 2014;8:55–60. DOI: 10.2147/OPTH.S53989

[74] Degenring R.F., Vey S., Kamppeter B., et al. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects // Graefes Arch Clin Exp Ophthalmol. 2007. Vol. 245, No. 1. P. 18–23. DOI: 10.1007/s00417-006-0377-4

[75] Degenring RF, Vey S, Kamppeter B, et al. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects. Graefes Arch Clin Exp Ophthalmol. 2007;245(1):18–23. DOI: 10.1007/s00417-006-0377-4

[76] Wielders L.H.P., Schouten J.S.A.G., Winkens B., et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1 // J Cataract Refract Surg. 2018. Vol. 44, No. 4. P. 429–439. DOI: 10.1016/j.jcrs.2018.01.029

[77] Wielders LHP, Schouten JSAG, Winkens B, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. 2018;44(9):1166. J Cataract Refract Surg. 2018;44(4):429–439. DOI: 10.1016/j.jcrs.2018.01.029

RIGHTS & PERMISSIONS

Wang X., Astakhov S.Y., Potemkin V.V., Potemkina A.R., Anikina L.K.